FDA, Health Canada, MHRA Issue Guiding Principles for Development of Good Machine Learning Practice

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA, Health Canada, MHRA Issue Guiding Principles for Development of Good Machine Learning Practice

Dennis Tosh

November 1, 2021 at 06:00 PM EST

The FDA, Health Canada, and the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) Oct. 27 issued a set of 10 guiding principles that the agencies said should be considered during the development of good machine learning practice (GMLP) guidelines, which are expected to “advance high-quality artificial intelligence/machine learning-enabled medical devi... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA, Health Canada, MHRA Issue Guiding Principles for Development of Good Machine Learning Practice

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT